Fennec's Pedmarqsi Gets Nod From U.K. Regulators

Seeking Alpha2024/12/21 05:24

Craig-Hallumはフェンネック ファーマシューティカルズ(FENC.US)のレーティングを強気にし

Craig-HallumのアナリストAlex Fuhrmanは$Fennec Pharmaceuticals(FENC.US)$のレーティングを強気にし。TipRanksのデータによると、このアナリストの最近1年間の的中率は39.2%、平均リターンは-0.1%である。注 TipRanksは、金融アナリストの分析データと、アナリストの的中率および平均リターンに関する情報を提供している独立第三者です。

Futuニュース2024/12/21 03:31

Fennec Pharmaceuticals Announces Pedmarqsi Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

GlobeNewswire2024/12/20 19:16

Fennec Pharmaceuticals Brief: Includes Elimination of Near US$1.5 Million in Annual Interest Expense and Potential Equity Overhang of Near 1.6 Million Shares

MT Newswires2024/12/19 19:15

Fennec Pharmaceuticals Brief: Announcing Early Partial Repayment of Its Outstanding Convertible Debt Facility With Petrichor Healthcare Capital Management

MT Newswires2024/12/19 19:14

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility With Petrichor Healthcare Capital Management

GlobeNewswire2024/12/19 19:13